The aim of this study was to investigate how the systemic inflammation response index (SIRI), systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR), taken individually and combined, are associated with overall survival (OS) in patients surgically treated for malignant salivary gland tumors (MSGTs).
The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy / Abbate, Vincenzo; Barone, Simona; Troise, Stefania; Laface, Claudia; Bonavolontà, Paola; Pacella, Daniela; Salzano, Giovanni; Iaconetta, Giorgio; Califano, Luigi; DELL'AVERSANA ORABONA, Giovanni. - In: CANCERS. - ISSN 2072-6694. - 14:23(2022), p. 5934. [10.3390/cancers14235934]
The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy
Vincenzo Abbate
;Simona Barone;Stefania Troise;Claudia Laface;Paola Bonavolontà;Daniela Pacella;Giovanni Salzano;Giorgio Iaconetta;Luigi Califano;Giovanni Dell’Aversana Orabona
2022
Abstract
The aim of this study was to investigate how the systemic inflammation response index (SIRI), systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR), taken individually and combined, are associated with overall survival (OS) in patients surgically treated for malignant salivary gland tumors (MSGTs).| File | Dimensione | Formato | |
|---|---|---|---|
|
80) Combination_cancer_Q1.pdf
solo utenti autorizzati
Licenza:
Dominio pubblico
Dimensione
3.08 MB
Formato
Adobe PDF
|
3.08 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
